Trial Profile
The Effects of Behavioral Counseling Plus Nicotine Replacement Therapy (NRT) or Varenicline on Smoking Cessation Among Smokers High and Low in Intrinsic Reward Sensitivity
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2023
Price :
$35
*
At a glance
- Drugs Varenicline (Primary) ; Nicotine
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 22 May 2023 Planned End Date changed from 1 Jun 2023 to 1 Jun 2024.
- 22 May 2023 Planned primary completion date changed from 1 Jun 2023 to 1 Jun 2024.
- 15 Jun 2022 Planned End Date changed from 1 Jun 2021 to 1 Jun 2023.